Capmatinib

• Target :

  C-Met/HGFR|||Apoptosis

• Related Pathways :

  Tyrosine Kinase/Adaptors|||Apoptosis

• Purity :

  0.9976

• Bioactivity :

  Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR) with potential antineoplastic activity.

• Smiles :

  CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1

• Molecular Formula :

  C23H17FN6O

• Molecular Weight :

  412.42

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1029712-80-8